ArticleAdvances in urology2026
Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study.
Article in Advances in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Renal Cell Carcinoma Texture Analysis With the KiTS23 Dataset: A Retrospective Study.Advances in urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Computed tomography texture analysis, powered by machine learning techniques, may differentiate clear cell renal cell carcinoma (ccRCC) from other renal tumor subtypes, such as papillary and chromophobe variants, or benign renal masses such as oncocytomas, as demonstrated here using the KiTS23 dataset. Methods: After excluding multifocal cases to avoid lesion-level labeling ambiguity and intrapatient lesion heterogeneity, 396 cases were included. Using PyRadiomics, 386 radiomics features were initially extracted from preprocessed computed tomography volumes and tumor segmentation masks. Subsequent multistage feature selection reduced the candidate feature set to 73 radiomics descriptors, and LASSO further selected six features for the primary classifier. Candidate machine-learning models were evaluated, with class-weighted Logistic Regression selected as the primary model. Threshold adjustment using the Youden index and bootstrap feature-selection stability analysis were performed. Results: The LASSO-selected class-weighted Logistic Regression model showed the best overall performance. Using the default probability threshold of 0.5, it achieved an accuracy of 76.5%, an area under the receiver operating characteristic curve of 80.4%, a precision of 91.2%, a sensitivity of 73.8%, and a specificity of 82.9% on the held-out test set. Youden-index thresholding increased sensitivity but reduced specificity; therefore, the fixed threshold of 0.5 was retained as the primary operating threshold. Bootstrap stability analysis showed that several LASSO-selected radiomics descriptors were repeatedly selected across resampled training cohorts. Conclusions: Radiomics-based machine learning shows promise for discriminating ccRCC from non-ccRCC renal tumors, but the results remain preliminary and have been evaluated internally. Given the moderate discrimination and lack of external validation, further studies using larger, multicenter datasets with standardized radiomics workflows are necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.